Spaventa Andrew

Track

Insider profile

Performance

Overall performance
3.5
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 52% 68% 82%
Transactions
5 40% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 63%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Spaventa Andrew's trades of Singular Genomics Systems Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-14 2025-02-14
S Sale
1,646 +16.5%
45.03
US$2,733,399 		1,646 +16.5% 45.03 US$2,733,399
2024-12-17 2024-12-16
S Sale
88,483 -25.7%
127.89
US$854,454 		88,483 -25.7% 127.89 US$854,454
2024-11-13 2024-11-12
S Sale
72,828 +49.0%
492.06
US$4,584,290 		72,828 +49.0% 492.06 US$4,584,290
2024-09-17 2024-09-15
S Sale
175 -21.6%
12.38
US$2,167 		175 -21.6% 12.38 US$2,167
2023-11-20 2023-11-17
B Purchase
75,000 +1.9%
0.42
US$31,755 		75,000 +1.9% 0.42 US$31,755
2023-11-20 2023-11-16
B Purchase
43,468 +1.1%
0.41
US$17,857 		43,468 +1.1% 0.41 US$17,857